InvestorsHub Logo
Followers 48
Posts 3935
Boards Moderated 0
Alias Born 01/26/2011

Re: stoneroad post# 187313

Saturday, 08/23/2014 5:27:10 PM

Saturday, August 23, 2014 5:27:10 PM

Post# of 346050
There's also the possibility that Bayer decided to make Yopp an offer he couldn't refuse to wait on publishing the data after chatting with him. An extra 2-3 quarters of wait time for Sorafenib to keep selling uninhibited by an HCC SOC threat emerging is worth hundreds of millions if not billions. Keep in mind he stated no Peregrine Pharmaceuticals disclosures.

Wah, wah...

But I don't believe that. If there is some good liver data coming, I wouldn't blame PPHM for keeping it close to the vest. Hell, we remember what happened last time they were outwardly excited. I also don't think that Yopp would turn on Brekken/PPHM considering how close our legal team is following that IST. MD got issued a threat by PPHM legal if he kept probing for info so I'd say their interests are all aligned. And that weekly CMF...

Only have to wait 2 weeks. I could see them issuing a proxy with a revers split, tanking the share price and then announcing huge news just to mess with us. This is, after all, the same company who announced the front-line failure during the Russell re-balancing.

Kyoto is also the same weekend as the conference in San Fran breast conference FWIW.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News